Luminopia is the first FDA-approved* binocular therapy for lazy eye (amblyopia). Luminopia treatment includes over 1,100 hours of popular TV inside a lightweight, immersive VR headset that is provided to the patient for the duration of their prescription. Our software algorithms take a selected show, modify it in real-time, and present it differently to each eye to rebalance the input to the brain, which has been shown to improve vision over time in appropriate patients with amblyopia. Luminopia can be prescribed by a trained eye-care professional in the United States.
*De Novo granted in Oct 2021.
Luminopia has been tested in 3 clinical trials with over 200 patients. Our gold standard Phase 3 pivotal trial demonstrated the safety and effectiveness of Luminopia in children aged 4-7 years. Patients who received Luminopia improved by 1.8 lines on average on a standard eye-chart after 12 weeks compared to 0.8 lines of improvement in the control group, which received glasses only.
Luminopia is indicated for improvement in visual acuity in amblyopia patients, aged 4 to <13, associated with anisometropia and/or with mild strabismus, having received treatment instructions (frequency and duration) as prescribed by a trained eye-care professional. The decision on whether your child is an eligible candidate for Luminopia should be made by your eyecare professional.
Luminopia is currently only approved for use in the United States.
Luminopia received marketing authorization from the FDA as a prescription-use medical device, and therefore, it is only available under the supervision of an eye-care professional.
Luminopia will provide a qualified headset for you to use for the duration of treatment!
Yes, currently a Wi-Fi network or smartphone hotspot is required to undergo treatment with Luminopia.
In the Luminopia Phase 3 pivotal trial, no serious adverse events (AEs) were reported. The most frequent non-serious AE potentially related to Luminopia was headache (14.3%), for which all cases were graded as mild, transient, and resolved on their own. No cases of nausea, worsening myopia, or reverse lazy eye (amblyopia) were reported.
Cybersecurity and patient data privacy are very important to us. With this in mind, Luminopia was designed based on industry leading standards for cybersecurity and patient data privacy. For more information, please refer to our Privacy Policy which can be found at luminopia.com/privacy.
Luminopia can be prescribed by a trained eye-care professional in the United States. Any eye doctor will be able to prescribe Luminopia. If your eye doctor is unfamiliar with Luminopia, they can find information on our website's "how to prescribe" section or reach out to us through our physician contact form (form for physicians only). If you'd like to find a doctor familiar with Luminopia near you, please fill out this form.
Luminopia is committed to ensuring affordable access for all patients. The treatment is offered as a monthly prescription and the team at our partner pharmacy, CoAssist, will help you find the lowest cost possible once they receive your prescripition.
When your eye-care professional writes you a prescription, our partner pharmacy, CoAssist, will automatically enroll you in our Patient Access Program. They'll contact your health plan on your behalf and let you know if Luminopia is covered by your plan. If it is not, CoAssist will offer a self-pay option so you can still access the treatment.
We recommend that you direct any medical questions to your eye-care professional. If you have questions about your prescription or questions about the treatment, please contact the Luminopia Patient Support Line at (855) 586-4756 or support@luminopia.com.
Toward the end of each 30-day prescription, our partner pharmacy CoAssist will reach out to you directly with a reminder to confirm your refill. If you do not hear from CoAssist, please call 855-382-2533.
Your access code for treatment should be in the text from our partner pharmacy, CoAssist, that includes your headset shipping notification and tracking number. The access code is the word in quotes right after "enter this Access Code to start treatment:". If you're having trouble locating the text, you can reach out to CoAssist directly at 855-382-2533 from 9 AM - 5 PM EST M-F.
This message could appear for two reasons:
To inquire about your prescription status you can reach out to CoAssist directly at 855-382-2533 from 9 AM - 5 PM EST M-F.
If you wish to return your headset, please contact CoAssist pharmacy at 855-382-2533, M-F from 9 AM - 5 PM EST to request a return label!
If your headset shows a visible imperfection on multiple screens (i.e. in the office screen and in the Luminopia library), reach out to Luminopia Support at (855) 586-4756 or support@luminopia.com to get a replacement charger or headset sent as soon as possible!
If it only appears over the video playing screen, this may be the grey masks that are a part of the treatment algorithm. In addition to the visuals being dulled in the strong eye with the reduction of contrast, complimentary parts of the image in each eye are blocked by these gray areas you are observing. This youtube video offers a great explanation of this with visual aids at 0:25 seconds!
This message appears when you haven’t logged out from the day before! Please fully power off the device by pressing and holding the power button until the Pico logo appears. Then power the device back on and log in as normal!
Reach out to Luminopia Support at (855) 586-4756 or support@luminopia.com for further assistance!
This issue is likely related to your internet connection. Please try these WiFi troubleshooting steps:
Reach out to Luminopia Support at (855) 586-4756 or support@luminopia.com for further assistance!
Ensure you are using the “Confirm Button” shown below on the right side of the device to select a WiFi network when hovering over it.
Ensure that the headset has been connected to WiFi, then reach out to Luminopia Support at (855) 586-4756 or support@luminopia.com for further assistance! (As a tip be ready to provide the device Serial Number located on the small white sticker on the top of the headset)
There are more than 3,100 episodes from over 75 popular, kid-friendly TV shows in the library, including animated and live action. All shows in the library are available to all patients with a Luminopia headset. The content library is updated regularly!
One hour per day, six days per week is the recommended dose authorized by the FDA based on the results of our Phase 3 pivotal clinical trial. Other treatment regimens have not been studied.
Within the application, there is a daily usage timer that shows the number of minutes remaining in your child’s treatment for the day. A pop-up will also appear at the end of each day reminding your child when treatment is over.
We recommend that all patients receive at least 3 months of treatment, since this was the duration studied in our Phase 3 pivotal clinical trial. After that, your eye-care professional will determine whether your child is continuing to benefit from Luminopia and decide whether to continue treatment.
The recommended treatment regimen for Luminopia is 1 hour of continuous use per day.
Luminopia is designed so that children can go through treatment while sitting upright, reclining, or lying down on their back. Choose a position that is most comfortable for your child.
Parents know their children best. Luminopia is designed to be engaging for patients, and a pop-up will appear when treatment is done for the day. Remind your child to remove the headset once the pop-up appears.
Yes, your child should always wear their glasses while using Luminopia.
.png)
